Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03085238

NCT03085238
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are a woman aged 18 or older
  • You have been diagnosed with Stage IIIC ovarian cancer
  • Your cancer is a specific type called high-grade serous carcinoma
  • You meet one of these surgery/treatment situations: (1) you had primary surgery to remove the tumor and a small amount of visible tumor (1 cm or less) remained; OR (2) you had 3 rounds of chemotherapy before surgery, and surgery completely removed all visible tumor; OR (3) you had 3 rounds of chemotherapy before surgery, and a small amount of visible tumor (1 cm or less) remained after surgery
  • You are generally well enough to carry out daily activities with little or no limitation (confirm with trial site)
  • You are willing and able to attend all required follow-up visits for the study
  • You are willing and able to sign a written consent form agreeing to take part

Who may not be able to join:

  • You are not expected to live longer than 3 months
  • You are pregnant, planning to become pregnant during the study, or are currently breastfeeding
  • You will be receiving chemotherapy delivered directly into the abdomen (rather than through a vein)
  • You have previously had radiation therapy to your abdomen or pelvis
  • You have serious ongoing health conditions, such as an active infection, heart failure, unstable chest pain, irregular heart rhythm, or a mental health or personal situation that would make it hard to follow the study requirements
  • Cancer has spread to your brain
  • Your ovarian cancer has come back after previous treatment
  • Your surgery completely removed all visible tumor during your first (primary) surgery with nothing remaining
  • More than 1 cm of visible tumor remained after your primary or interval surgery
  • You are currently taking part in another clinical research study
  • You have had another type of cancer in the past 5 years, other than a very early-stage cervical cancer or certain non-serious skin cancers
  • You are known to have an allergic reaction to carboplatin or paclitaxel (common chemotherapy drugs)
  • You are currently using other cancer-fighting treatments at the same time

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
MTrap, Inc.
Registry
clinicaltrials_gov
Start date
9 March 2017
Est. completion
12 September 2018

Where this trial is recruiting

🇪🇸 Spain

Primary endpoints

Safety: Number of Participants With Freedom From Device and Procedure-related Major Adverse Events; Safety: Number of Participants With Freedom From Device and Procedure-related Major Adverse Events; Performance: Number of Participants With Histological Evidence of Tumor Cell Capture

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov